Kun Tu
Impact in
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
-
- Immunotherapy and Immune Responses
- Immune cells in cancer
Papers in
- Oncology 6
- CAR-T cell therapy research 2
- Drug Transport and Resistance Mechanisms 2
- Cancer Treatment and Pharmacology 1
-
- Immunotherapy and Immune Responses 5
- Immune cells in cancer 3
- Co-authors
- Li Kong (7 shared papers)Qian Hu (5 shared papers)Zhiping Zhang (4 shared papers)Mei Hu (4 shared papers)Yulin Yu (4 shared papers)Ting Yang (4 shared papers)Conglian Yang (4 shared papers)Xianya Qin (3 shared papers)
- Journals
- ACS Applied Materials & Interfaces (2 papers)Biomaterials (1 paper)Acta Pharmaceutica Sinica B (1 paper)Colloids and Surfaces B Biointerfaces (1 paper)International Journal of Pharmaceutics (1 paper)
- Partner nations
- ChinaMacaoUnited Kingdom
In The Last Decade
Kun Tu
12 papers receiving 526 citations
Peers
Comparison fields: 5 of 63
- Biomaterials 123
- Immunology 167
- Biomedical Engineering 231
- Oncology 142
- Pharmaceutical Science 23
Countries citing papers authored by Kun Tu
This map shows the geographic impact of Kun Tu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kun Tu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kun Tu more than expected).
Fields of papers citing papers by Kun Tu
This network shows the impact of papers produced by Kun Tu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kun Tu. The network helps show where Kun Tu may publish in the future.
Co-authors
The 25 scholars most cited alongside Kun Tu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 137 | |
| 2 | 2020 | 99 | |
| 3 | 2019 | 77 | |
| 4 | 2021 | 51 | |
| 5 | 2020 | 48 | |
| 6 | 2019 | 28 | |
| 7 | 2018 | 23 | |
| 8 | 2020 | 21 | |
| 9 | 2020 | 20 | |
| 10 | 2018 | 12 | |
| 11 | 2018 | 12 | |
| 12 | 2025 | 1 |
About Kun Tu
Kun Tu is a scholar working on Oncology, Immunology, Biomedical Engineering, Molecular Biology and Biomaterials, having authored 12 papers that have together received 529 indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (5 papers), Immunotherapy and Immune Responses (5 papers), Nanoparticle-Based Drug Delivery (3 papers), Immune cells in cancer (3 papers), Extracellular vesicles in disease (2 papers), CAR-T cell therapy research (2 papers), Drug Transport and Resistance Mechanisms (2 papers) and Cancer Treatment and Pharmacology (1 paper). The work is most often cited by research in Biomaterials (123 citations), Immunology (167 citations), Biomedical Engineering (231 citations), Oncology (142 citations) and Pharmaceutical Science (23 citations). Kun Tu has collaborated with scholars based in China, Macao and United Kingdom. Frequent co-authors include Li Kong, Qian Hu, Zhiping Zhang, Mei Hu, Yulin Yu, Ting Yang, Conglian Yang, Xianya Qin, Huan Deng and Zhiping Zhang. Their work appears in journals such as ACS Applied Materials & Interfaces, Biomaterials, Acta Pharmaceutica Sinica B, Colloids and Surfaces B Biointerfaces and International Journal of Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.